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Background
The success of an HIV vaccine clinical trial depends not
only on scientific discovery but also upon the participa-
tion of healthy volunteers. In HIV vaccine clinical
research, strategic and timely information dissemination
to target audiences strengthens a culture of awareness,
understanding, and support for trial participation. Tradi-
tional approaches for information sharing have included
print media, radio, television, and face-to-face engage-
ment. As trends in online use surge among all popula-
tions, the Vaccine Research Center (VRC) Clinical Trials
Core (CTC) has launched a communications initiative uti-
lizing social media.
Methods
In 2007, the VRC CTC began utilizing social media venues
YouTube, Wikipedia, Facebook, and Craigslist to commu-
nicate with priority populations. The VRC also undertook
a website revision to better engage online audiences.
Social media and website analytics have been closely
monitored to optimize visitor's experience and takeaways
by tracking navigation pathways, referral links and visit
frequency. The referral source for clinical trial participants
has also been monitored for links to social media.
Results
The revised Vaccine Research Center website receives an
average of 137 visits per day with an average visit length
of 4:23 minutes, totaling 11,453 visits for Q1 2009. Social
media sources account for nearly 25% of referring
domains for website traffic and 16% of referral sources
named by VRC clinical trial participants.
Conclusion
The regular and timely utilization of social media venues
broadens VRC CTC outreach capacity. A valuable return
on investment is seen in both website visitor traffic and in
volunteer referral sources. Website analytics have guided
investment into new features i.e. e-card marketing and
online participant screening. User and outcome analysis
of social media venues has also informed decision-mak-
ing for greater entry into new media utilization including
micro-blogging. The use of social media enables interac-
tive communication, content exchange and the opportu-
nity to reach broader audiences.
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